These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Nursing care of the patient with chronic occlusive peripheral artery disease. Boozer M; Craven RF Cardiovasc Nurs; 1981; 17(4):13-7. PubMed ID: 6911062 [No Abstract] [Full Text] [Related]
10. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy]. Cascio F Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567 [No Abstract] [Full Text] [Related]
11. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries]. Zhang GS Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146 [No Abstract] [Full Text] [Related]
12. The excretion of 5-hydroxyindoleacetic acid in normal and vascular deficient human subjects. Zawrocka-Wrzolkowa T Bull Acad Pol Sci Biol; 1965; 13(10):619-21. PubMed ID: 5887195 [No Abstract] [Full Text] [Related]
13. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases]. Perzanowski A; Bielawiec M; Myśliwiec M Pol Tyg Lek; 1972 Jan; 27(5):174-6. PubMed ID: 5010762 [No Abstract] [Full Text] [Related]
14. [Is the prognosis of arterial circulation disorders influenced by a deep venous thrombosis of the leg?]. Gumrich H Med Welt; 1966 Nov; 46():2500-6. PubMed ID: 5979453 [No Abstract] [Full Text] [Related]
15. Early recognition of peripheral vascular insufficiency. Lippmann HI Proc Rudolf Virchow Med Soc City N Y; 1972-1973; 29():41-8. PubMed ID: 4531048 [No Abstract] [Full Text] [Related]
16. Transcutaneous PO2 response to transient arterial occlusion in peripheral occlusive disease. Esato K; O-Hara M; Mohri H Int Surg; 1987; 72(2):115-8. PubMed ID: 3610537 [TBL] [Abstract][Full Text] [Related]
17. NEUROVASCULAR DISORDERS OF THE UPPER EXTREMITY TREATED BY TRANSAXILLARY SYMPATHECTOMY. KLEINERT HE; COOK FW; KUTZ JE Arch Surg; 1965 Apr; 90():612-6. PubMed ID: 14267664 [No Abstract] [Full Text] [Related]
18. [Role of lysosomal enzymes in the pathogenesis of peripheral arterial diseases]. Knapik-Kordecka M Pol Arch Med Wewn; 1983 Jun; 69(6):401-6. PubMed ID: 6359085 [No Abstract] [Full Text] [Related]
19. [Arteriosclerosis obliterans and Buerger's disease]. Ishimaru S; Yao Y Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930 [No Abstract] [Full Text] [Related]
20. [Effect of carbogaseous baths in the treatment of chronic peripheral obliterating arteriopathies]. Brassai Z; Horváth E; Csögör I; Ferencz L; Benedek G; Szász B Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):603-8. PubMed ID: 4453683 [No Abstract] [Full Text] [Related] [Next] [New Search]